High impact
Belimumab (Benlysta) (CPB 0818, reviewed 2026-06-10)
Aetna·Effective Jun 10, 2026
HCPCS J7638 is officially defined as "Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram." HCPCS J7638 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J7638 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.